ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04211	Longevity regulating pathway	5/25	123/7206	5.39694089591e-05
ko05130	Pathogenic Escherichia coli infection	4/25	77/7206	0.000128584386898
ko05210	Colorectal cancer	4/25	86/7206	0.000197572612822
ko04810	Regulation of actin cytoskeleton	6/25	264/7206	0.000224720795528
ko05100	Bacterial invasion of epithelial cells	4/25	99/7206	0.000339745618506
ko01521	EGFR tyrosine kinase inhibitor resistance	4/25	106/7206	0.000441068092538
ko04910	Insulin signaling pathway	4/25	172/7206	0.00267883585638
ko05131	Shigellosis	3/25	82/7206	0.00272691871235
ko05167	Kaposi's sarcoma-associated herpesvirus infection	4/25	191/7206	0.00391007312888
ko05132	Salmonella infection	3/25	98/7206	0.004515262411
ko04921	Oxytocin signaling pathway	4/25	209/7206	0.00538931199802
ko04666	Fc gamma R-mediated phagocytosis	3/25	122/7206	0.00829780201963
ko05020	Prion diseases	2/25	40/7206	0.0083149884968
ko01522	Endocrine resistance	3/25	124/7206	0.00867647474829
ko04215	Apoptosis - multiple species	2/25	47/7206	0.011354281702
ko04722	Neurotrophin signaling pathway	3/25	160/7206	0.0172676634666
ko04152	AMPK signaling pathway	3/25	161/7206	0.0175555610879
ko04071	Sphingolipid signaling pathway	3/25	162/7206	0.0178461697128
ko04932	Non-alcoholic fatty liver disease (NAFLD)	3/25	182/7206	0.0242308552767
ko05200	Pathways in cancer	5/25	492/7206	0.0247208128585
ko04150	mTOR signaling pathway	3/25	184/7206	0.0249295400832
ko04141	Protein processing in endoplasmic reticulum	3/25	184/7206	0.0249295400832
ko05152	Tuberculosis	3/25	187/7206	0.0259981408924
ko05014	Amyotrophic lateral sclerosis (ALS)	2/25	74/7206	0.026799039547
ko04115	p53 signaling pathway	2/25	74/7206	0.026799039547
ko01524	Platinum drug resistance	2/25	76/7206	0.0281586422046
ko04144	Endocytosis	4/25	342/7206	0.0286302565484
ko04530	Tight junction	3/25	228/7206	0.0430649272113